iShares Trust - iShares Nasdaq Biotechnology ETF

IBB

US4642875565

IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2023

Published on 12/01/2023 at 09:30 am EST

S&P Capital IQ

ISHARES TRUST - ISHARES NASDAQ BIOTECHNOLOGY ETF

+0.31%

iShares Trust - iShares Biotechnology ETF reported earnings results for the half year ended September 30, 2023. For the half year, the company reported revenue was USD 25.78 million. Net loss was USD 403.36 million.

Latest news about iShares Trust - iShares Nasdaq Biotechnology ETF

Dec. 14	IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on December 19, 2025	CI
25-09-14	IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on September 19, 2025	CI
25-03-16	IShares Trust - iShares Biotechnology ETF announces Quarterly dividend, payable on March 21, 2025	CI
24-12-03	IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2024	CI
24-06-04	IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2024	CI
23-12-01	IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2023	CI
23-06-01	IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2023	CI
21-06-04	IShares Trust - iShares Nasdaq Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2021	CI
20-06-04	Ishares Trust - Ishares Nasdaq Biotechnology Etf Reports Earnings Results for the Full Year Ended March 31, 2020	CI
19-12-05	Ishares Trust - Ishares Nasdaq Biotechnology Etf Reports Earnings Results for the Half Year Ended September 30, 2019	CI
19-06-07	IShares Trust - iShares Nasdaq Biotechnology ETF Announces Audited Earnings Results for the Full Year Ended March 31, 2019	CI

Chart iShares Trust - iShares Nasdaq Biotechnology ETF

Duration

Period

Chart iShares Trust - iShares Nasdaq Biotechnology ETF

IBB: Dynamic Chart

Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Employees

Sector

Investment Trusts

More about the company